Empagliflozin gets FDA Fast-Track status for Chronic Heart Failure Treatment Deepanjana Sarkar28 Jun 2019 7:30 PM ISTThe U.S Food and Drug Administration has tagged sodium-glucose co-transporter 2 (SGLT2) inhibitor Empagliflozin with Fast-Tracked designation for the...
Warning-SGLT2 Inhibitors may mask ketoacidosis preoperatively, prove fatal Hina Zahid22 July 2019 10:20 AM ISTSGLT2 Inhibitors may mask a lethal complication of diabetes namely ketoacidosis at the time of surgery and prove fatal, finds a new study.SGLT2...
Empagliflozin also protects against heart disease in addition to regulating blood sugar, finds study Dr. Kamal Kant Kohli Kohli1 Sept 2019 10:00 AM ISTEmpagliflozin helps regulate blood sugar and can also protect against heart disease, finds new study. The researchers at St. Michael's Hospital in...
Oral semaglutide bests empagliflozin in reducing weight and HbA1c in diabetes Medha Baranwal Baranwal1 Nov 2019 8:28 PM ISTDelhi: Oral semaglutide, glucagon-like peptide 1 (GLP-1) analog, outperformed sodium-glucose cotransporter 2 (SGLT2) inhibitor empagliflozin in...
Empagliflozin may not increase exercise ability in chronic heart failure: Phase III Trials Hina Zahid16 Dec 2019 7:20 PM ISTRIDGEFIELD, Conn. and INDIANAPOLIS -- The results from the EMPERIAL-Reduced and EMPERIAL-Preserved trials related to functional endpoints with...
SGLT2 inhibitors reduce risk of heart attack and death: BMJ Deepanjana Sarkar2 Sept 2019 8:28 PM ISTBlood sugar lowering agents SGLT2 inhibitors lower risk of heart attack and death finds a new study.Type 2 diabetes drug, sodium-glucose transport...
SGLT2 inhibitors do not increase bladder cancer risk, contrary to concerns raised Medha Baranwal Baranwal28 July 2019 7:25 PM ISTFlorence, Italy: Widely used medications for type 2 diabetes, SGLT‐2 inhibitors, do not increase the risk of cancer in general or, bladder cancer in...
SGLT2 inhibitor empagliflozin promotes more weight loss than Metformin in PCOS Medha Baranwal Baranwal14 Jun 2019 8:28 PM ISTUK: Women with polycystic ovary syndrome (PCOS) and obesity who received the diabetes drug SGLT2 inhibitor empagliflozin lost more weight and had a...
Should cardiologists prescribe SGLT2 Inhibitor routinely to all Medha Baranwal Baranwal11 April 2019 7:03 PM ISTSGLT2 inhibitors are introduced primarily as glucose-lowering drugs but the new analysis of DECLARE-TIMI 58 trial gave startling revelations that...
PERSPECTIVE: Diabetes management with SGLT2 inhibitors changing directions- Dr Anoop Misra, Dr Amrita Ghosh Deepanjana Sarkar31 March 2019 8:28 PM ISTThere have been remarkable changes in the treatment of type 2 diabetes during the last decade. Focus has shifted from older class of drug (except...
